$Protagonist Therapeutics, Inc. Common Stock(PTGX)$ 8-K - Current report Filed: 2017-05-30 AccNo: 0001193125-17-186271 Size: 23 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接